XRP’s price saw a sharp rebound after a recent slump, driven by strong inflows into newly launched spot XRP ETFs. On November 24, these funds attracted $164 million in net inflows, marking the second-largest single-day total since the ETFs began trading, according to SoSoValue. This surge indicates a growing interest in the cryptocurrency. Source: SoSoValue […]XRP’s price saw a sharp rebound after a recent slump, driven by strong inflows into newly launched spot XRP ETFs. On November 24, these funds attracted $164 million in net inflows, marking the second-largest single-day total since the ETFs began trading, according to SoSoValue. This surge indicates a growing interest in the cryptocurrency. Source: SoSoValue […]

XRP Price Surges as Spot ETFs See Record $164M Inflows

2025/11/25 19:52
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • XRP price rebounds with $164M in ETF inflows, signaling growing investor interest.
  • Grayscale and Franklin Templeton lead with heavy investments in Ripple ETFs.
  • Analysts predict Ripple supply could be absorbed in under six months with strong inflows.

XRP’s price saw a sharp rebound after a recent slump, driven by strong inflows into newly launched spot XRP ETFs. On November 24, these funds attracted $164 million in net inflows, marking the second-largest single-day total since the ETFs began trading, according to SoSoValue. This surge indicates a growing interest in the cryptocurrency.

Source: SoSoValue

Grayscale’s GXRP ETF took the lead with $67.36 million on its launch day. Franklin Templeton’s XRPZ ETF followed it up with $62.59 million. These heavy investments demonstrate that both retail and institutional investors are interested in Ripple.

XRP’s Price Gains 5.7% as ETFs Continue to Attract Strong Investments

The recent inflows are the seventh consecutive day that positive investment in Ripple ETFs occurred. This is also the second-largest inflow day since the launch of Canary’s XRPC fund. XRPC has now reached $306 million in assets with strong momentum even as it sits in the 231st position globally.

As a result of these significant ETF investments, the price of altcoin rose more than 5.7%, according to CoinMarketCap. The increase is showing the direct impact of Ripple-related ETFs on its market value. 

Crypto analyst Chad Steingraber views this as the beginning of a longer-term bull trend for Ripple in the same way that Bitcoin ETFs did in the past.

Also Read: Franklin Templeton Debuts New XRP ETF, XRPZ

New ETFs Set to Fuel Growth in Ripple Market Demand

Steingraber compared Ripple ETFs with Bitcoin ETFs and noted that Bitcoin’s ETFs had more than $1 billion in inflows on multiple days. He suggests Ripple ETFs could take a similar path, estimating it could take $83M per fund to spark a $1 billion day’s worth of inflows. With 12 active Ripple ETFs, this could quickly become a reality.

If the current pace of inflows continues, Steingraber believes the circulating supply of Ripple could be significantly reduced. He approximates that a five-day run of billion-dollar inflows will possibly absorb more than 2.2 billion Ripple. This could push the price even higher, which will benefit the holders of tokens and the overall market.

More Ripple ETFs are also coming soon. 21Shares was automatically approved by the SEC for its ETF, and it will soon trade on the Cboe BZX Exchange. CoinShares has also revised its Nasdaq debut filing, indicating an increase in institutional exposure for the token.

Steingraber also noted that major asset managers such as BlackRock could speed the absorption of token supply. With institutional participation, the process might be shorter than six months. However, he noted that the most important factor in this scenario is the price of Ripple. To balance the increasing demand, there must be a strong increase in the price.

Also Read: XRP Drops to $2.08 as GXRP ETF Launch Fails to Lift Price: 3 Key Levels to Watch

Market Opportunity
XRP Logo
XRP Price(XRP)
$1,3706
$1,3706$1,3706
-1,57%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11